Advanced search
Publication Cover
Bioanalysis Volume 7, 2015 - Issue 21
Submit an article Journal homepage
1,070
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Metabonomic Diagnosis of Bladder Cancer: What are The Advantages and Considerations?

Yanjun Hong1 Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543SingaporeView further author information
,
Kesavan Esuvaranathan2 Department of Surgery, National University Health System, 5 Lower Kent Ridge Road, 119074SingaporeView further author information
,
Kishore Kumar Pasikanti1 Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543SingaporeView further author information
&
Eric Chun Yong Chan1 Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, 117543SingaporeCorrespondence[email protected]
View further author information
Pages 2727-2729 | Published online: 13 Nov 2015

References

  • Siegel R , WardE, BrawleyO, JemalA. Cancer statistics, 2011. CA: Cancer J. Clin. 61 (4), 212–236 (2011).
  • Urquidi V , RosserCJ, GoodisonS. Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis. Curr. Med. Chem. 19 (22), 3653–3663 (2012).
  • Mitra AP , CoteRJ. Molecular screening for bladder cancer: progress and potential. Nat. Rev. Urol. 7 (1), 11–20 (2010).
  • Lotan Y , RoehrbornCG. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses. Urology61 (1), 109–118 (2003).
  • Chan EC , PasikantiKK, HongYet al. Metabonomic profiling of bladder cancer. J. Proteome Res. 14 (2), 587–602 (2015).
  • Robinson VL , PorterM, MessingEet al. BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress. Urol. Oncol. 28 (3), 334–337 (2010).
  • Nicholson JK , LindonJC, HolmesE. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29 (11), 1181–1189 (1999).
  • Pasikanti KK , EsuvaranathanK, HoPCet al. Noninvasive urinary metabonomic diagnosis of human bladder cancer. J. Proteome Res. 9 (6), 2988–2995 (2010).
  • Bansal N , GuptaA, MitashNet al. Low-and high-grade bladder cancer determination via human serum-based metabolomics approach. J. Proteome Res. 12 (12), 5839–5850 (2013).
  • Pasikanti KK , EsuvaranathanK, HongYet al. Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry. J. Proteome Res. 12 (9), 3865–3873 (2013).
  • Issaq H , NativO, WaybrightTet al. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry. J. Urol. 179 (6), 2422–2426 (2008).
  • Huang Z , LinL, GaoYet al. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach. Mol. Cell. Proteomics10 (10), M111.007922 (2011).
  • Huang Z , ChenY, HangWet al. Holistic metabonomic profiling of urine affords potential early diagnosis for bladder and kidney cancers. Metabolomics9 (1), 119–129 (2013).
  • Jin X , YunSJ, JeongP, KimIY, KimWJ, ParkS. Diagnosis of bladder cancer and prediction of survival by urinary metabolomics. Oncotarget5 (6), 1635–1645 (2014).
  • Cao M , ZhaoL, ChenH, XueW, LinD. NMR-based metabolomic analysis of human bladder cancer. Anal. Sci. 28 (5), 451–456 (2012).
  • Monteiro M , CarvalhoM, BastosM, Guedes de PinhoP. Metabolomics analysis for biomarker discovery: advances and challenges. Curr. Med. Chem. 20 (2), 257–271 (2013).
  • Weiss RH , KimK. Metabolomics in the study of kidney diseases. Nat. Rev. Neurol. 8 (1), 22–33 (2012).
  • Balog J , Sasi-SzabóL, KinrossJ. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci. Transl. Med. 5 (194), 194ra93 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.